|
Linya Group Co., LTD Linya Group Ltd was established in November 1996. Prior to this our aluminium extrusion tubing company has traded since 1992. With the support of government policy, both national and local, Linya has worked hard to create a diversified group spanning investment, manufacturing, property and energy development sectors.
The group turns over million USD and exports million USD with capital assets of million USD. The manufacturing division covers an area of some 650 acres with a staff of over 5,000.
Linya is a leading business in Linhai city and is proud to promote local economic development. This has been recognised by the numerous awards we have achieved, including “Best private Enterprise” in Zhejiang province.
1、 Manufacturing
Linya aluminium extrusion tubing company is the most advanced manufacturing facility of aluminum alloy in eastern China. The factory covers an area of some 58,000 square meters with capital assets of 1million USD and has 16 aluminums profile extrusion lines.
The factory has equipment for anodic oxidation, electrophoresis paint and electrostatic spraying. Annual production capacity is 2 million tons. We have passed the ISO9001 quality system and have been recognized as the national nonferrous metal industry's most large-scale enterprise through the national metrology authentication unit. Our aluminum is used in construction, decoration and consumer products. The aluminum product is regarded as "the Chinese famous brand".
Zhejiang Linya craftwork Company Ltd covers an area of more than 200, 000 square meters, with a total investment of 2million USD. Our main products are outdoor leisure furniture, camping products, gazebos and sunshades. Every year, Linya exports more than 120 million dollars to Europe, America and Japan.
In July 2000 Linya obtained the import-export right. In October 2001 we obtained ISO9000 (2000) quality system authentication and related GS, CE certification.
Linya continually increases industrial infrastructure investment and enhances vertical integration to control quality and costs. In recent years the company invested ?million USD in industrial projects and invests heavily in technical renovation. This year the group invested ?USD in the updating of capital equipment to enable leaner and higher quality manufacturing and drive our competitive advantage.
2、Hydro-Electric Energy development
As part of Chinas’ national strategy to implement power transmission from west to east Linya have completed a hydropower scheme in Sichuan, Yunnan. This forms part of our group diversification strategy and the dam has a capacity of 0.5 Million Kilowatts. These projects give Linya Group long term revenue streams and strengthen our cashflow.
3、Propery and Investment business
Rct 406 Safe-no · Instant & Top-Rated
RCT 406 Safe-No refers to a specific type of clinical trial design that prioritizes safety above all else. The “Safe-No” designation indicates that the trial is designed to test the safety of a new treatment or intervention, rather than its efficacy. In other words, the primary objective of an RCT 406 Safe-No trial is to assess the safety profile of a new treatment, rather than its effectiveness in treating a particular condition.
RCT 406 Safe-No: Understanding the Concept and Its Implications** Rct 406 Safe-no
The term “RCT 406 Safe-No” has been gaining attention in recent times, particularly in the context of clinical trials and medical research. RCT stands for Randomized Controlled Trial, which is a type of scientific experiment used to evaluate the effectiveness and safety of new treatments, medications, or interventions. In this article, we will delve into the concept of RCT 406 Safe-No, its significance, and the implications it has on medical research and practice. RCT 406 Safe-No refers to a specific type
In conclusion, RCT 406 Safe-No trials play a critical role in the development of new treatments and medications. By prioritizing safety, these trials help to ensure that new treatments are safe for use in humans. While they have several challenges and limitations, the implications of RCT 406 Safe-No trials are far-reaching and have significant impacts on medical research and practice. As the medical research landscape continues to evolve, it is likely that RCT 406 Safe-No trials will remain an essential component of the clinical trial process. RCT 406 Safe-No: Understanding the Concept and Its
In 1999, the group invested 8 million yuan in Jiuzhaigou Valley Sichuan province to build the four-star “Gesang Hotel”. The Building area is 30,000 square meters and has 310 rooms. Facilities include a Chinese and Western restaurant, recreation and performance hall, sauna, tea room and conference room.
In 2008, the group established Linya loan company Ltd. with registered capital of 20 million USD. The main function is to support the cash flow of local small and medium sized companies. This company continues to offer efficient service to local companies and works to enhance the areas economic prosperity.
|
